News

Aramis Group Reports Half-Yearly Liquidity Contract Insights

Aramis Group Reports Half-Yearly Liquidity Contract Insights

Aramis Group Reports Significant Growth in Liquidity Contract

Aramis Group has recently shared a detailed account of its liquidity contract, which has been managed with the expertise of Kepler Cheuvreux. As of June 30, 2025, the group has made notable advancements in its financial strategy, indicating a robust position in the market.

Current Assets Demonstrating Strength

The liquidity account at the end of June displayed substantial resources, including 43,333 shares valued at €953,724. This marks a significant increase from the previous year, illustrating the company’s growing stability.

To provide context, at the end of the last reporting period, on December 31, 2024, the liquidity account reflected only 11,781 shares and €1,135,692. This dramatic growth highlights the company’s successful strategies and investor confidence.

Transaction Highlights

From January 1 to June 30 of this year, Aramis Group experienced considerable transaction activity. The data reveals that during this half-year period, the company executed a total of 890 purchase transactions, accumulating 292,527 shares, which amounted to €1,820,606.84.

Notable Sales Activity

In parallel, the sales side was equally impressive, with 1,038 sales transactions resulting in 350,246 shares sold for €2,198,866.14. This contrasts with the purchasing activity, underscoring the balance Aramis Group maintains in managing its assets.

About Aramis Group

Aramis Group stands as a leader in the European B2C online used car sales industry, making waves in six different countries. As an innovative and rapidly growing company, it has established itself as an expert in e-commerce and vehicle refurbishing. This dedication contributes significantly to sustainable mobility and the circular economy.

Founded in 2001, Aramis Group has transformed the competitive landscape over the past two decades, continually focusing on customer satisfaction, digital innovation, and employee engagement to enhance value for all stakeholders involved. The company has reported annual revenues exceeding €2 billion and facilitates over 110,000 vehicle sales to consumers while attracting nearly seventy million visitors across its digital platforms annually.

With a dedicated workforce of over 2,400, the group operates eight large-scale refurbishing centers across Europe, showcasing its operational scale and efficiency. As a recognized entity on Euronext Paris Compartment B, it trades under the ticker ARAMI – ISIN: FR0014003U94, reflecting its commitment and relevance in today’s marketplace.

Contact Information for Stakeholders

For inquiries and further communications, Aramis Group encourages stakeholders to connect through the following channels: For investor relations, reach out to investor@aramis.group. For press-related inquiries, please contact Brunswick, specifically Hugues Boëton or Tristan Roquet Montegon.

For additional assistance, you may also reach aramisgroup@brunswickgroup.com or call +33 (0)6 79 99 27 15. Our dedicated team is ready to provide support and information as needed.

Frequently Asked Questions

What is the purpose of the liquidity contract?

The liquidity contract helps manage the trading of shares effectively and provides visibility into the company's financial stability.

How many shares did Aramis Group report as of June 30, 2025?

As of June 30, 2025, Aramis Group reported 43,333 shares in its liquidity account.

What were the total transactions from January to June 2025?

During this period, Aramis Group engaged in 890 purchases and 1,038 sales transactions.

What does Aramis Group focus on?

Aramis Group specializes in online used car sales and vehicle refurbishment, promoting sustainable and circular economic practices.

How can investors contact Aramis Group?

Investors can reach Aramis Group at investor@aramis.group for inquiries and information.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Infotech's 2026 Report Crowns PSA Software Leaders

Updated Category News Views 20

Spotlight on PSA Trailblazers It's 2026, and Infotech has dropped its latest bombshell—the Professional Services Automation Data Quadrant Report. This ain't just your run-of-the-mill software rankings; it's a peek into tools that could make or break project management for service-oriented businesses. Five top dogs, RocketLane, Wrike, Accelo, SAP Professional Services...

Continue Reading
NORROY's Radiopharma Innovations: EANM Highlights

Updated Category News Views 93

Breaking Ground: NORROY's Radiopharmaceutical Innovations If you thought the radiopharmaceutical game was stuck in the same ol' rut, NORROY Bioscience just flipped the script. Standing out at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM'26) in Vienna, they trotted out enough breakthroughs to make you wonder if they're secretly running on...

Continue Reading
AlphaESS Secures Fifth Tier 1 Status Amid Growth

Updated Category News Views 177

AlphaESS: Consistency Breeds Success Can't ignore a company that keeps hitting the marks quarter after quarter, kid. AlphaESS just bagged its fifth consecutive Tier 1 status from BloombergNEF for Q4 2026—that's no joke in the buzzing world of energy storage. What makes this outfit tick? It's not just sticking to the same old script; they keep leveling up while everyone...

Continue Reading
GomSpace Eyes SEK 1.6 Billion Revenue by 2030

Updated Category News Views 135

Cracking Open GomSpace's Q3 Gains You don't just stumble upon profitability in this market; that's for sure. GomSpace, however, seems to have a knack for finding its stride amidst the chaos. In their latest earnings report, it looks like they're not just coasting—they're powering through with profitable growth in the third quarter. Who would have thought? These folks...

Continue Reading
Survey Reveals 'TDS' Impact on 2026 Midterm Elections

Updated Category News Views 93

Midterms and 'Trump Derangement Syndrome': What's the Deal? Every election season there's something new to raise eyebrows, and this time it's 'Trump Derangement Syndrome' (TDS) taking the spotlight. After the dust of the 2026 mid-terms started settling, it turns out there's more than just traditional candidate bickering shaping votes. Can you guess what's driving voters?...

Continue Reading
KT&G Soars with Record Profits, Aggressive Share Buybacks

Updated Category News Views 73

KT&G Climbs to New Heights with Record-Setting Q3 If you're eyeballing the markets like a hawk, KT&G (KRX: 033780) just gave you something to squawk about. In the world of stocks, milestones are few and far between, but KT&G is handing out milestones like candy in Q3. They rolled out their numbers for the quarter, and let me tell ya, this was no pie-in-the-sky nonsense....

Continue Reading
SKF's Industrial Push: Energy Efficiency at COP31

Updated Category News Views 73

SKF's Green Initiative: A Major Step Forward You ever find yourself in a room full of big players, each trying to outdo the other? That's the stage set for SKF at COP31, where they're not just strutting around showing off but actually offering some substance—a rarity in these highbrow gatherings. They're juicing up the talk around energy efficiency and circularity...

Continue Reading
Magnolia Data Breach: Legal Stakes Loom for Seniors

Updated Category News Views 192

Elderly Residents at Risk After Data Breach Well, here we go again — another day, another data breach debacle. This time, it's Magnolia Management putting senior residents' sensitive information on a silver platter for potential cyber intruders. We're talking names, Social Security numbers, and medical records — the whole shebang. When you're handling such crucial...

Continue Reading
Multi-Society Panel Boosts Vaccine Guidance Clarity

Updated Category News Views 23

Vaccination Confusion: Could Clarity Finally Be Here? Here's the scoop, folks. In the swirling mess of immunization advice, a coalition of top medical societies has thrown a lifeline to clinicians. If you're drowning in conflicting vaccine guidance, this panel's unified stance might just be your life raft. The Coalition Forces of Immunization We have the Vaccine Guidance...

Continue Reading
Bram Schot Steers Marelli Through Chapter 11 Resurgence

Updated Category News Views 97

So, Marelli's rolling out the heavy artillery with the appointment of Bram Schot as their future Chair. This isn't just reshuffling a few chairs on the deck of a wobbly ship. No, Marelli's emergence from Chapter 11, with Schot at the helm, is more akin to a full-blown course correction. The man comes seasoned, having braved the corporate gales at Audi, Mercedes-Benz, and...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading